Lanean...
Staging Biomarkers in Preclinical Autosomal Dominant Alzheimer Disease by Estimated Years to Symptom Onset
INTRODUCTION: Staging preclinical Alzheimer disease (AD) by the expected years to symptom onset (EYO) in autosomal dominant AD (ADAD) through biomarker correlations is important. METHODS: We estimated the correlation matrix between EYO/cognition and imaging/CSF biomarkers, and searched for the EYO c...
Gorde:
| Argitaratua izan da: | Alzheimers Dement |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6461496/ https://ncbi.nlm.nih.gov/pubmed/30773445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2018.12.008 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|